Table 1.
Characteristics of included studies comparing oral contraceptive pill (OCP) users and OCP non-users following matched resistance exercise training interventions
Study | n | Training status | Intervention duration (weeks) | Supervised training | Outcomes | Results OCP versus non-users | Study conclusion | Methodological quality score |
---|---|---|---|---|---|---|---|---|
Dalgaard et al., 2019 [20] |
OCP-users: 14 Naturally menstruating: 14 |
Untrained | 10 | Yes | Hypertrophy: | Use of OCPs was associated with a trend towards a greater increase in muscle mass and a significantly greater increase in type I muscle fibre area compared with controls. Use of OCPs did not influence the overall increase in muscle strength related to training | 12 | |
MRI: | ||||||||
Vastus lateralis muscle CSA | ↔ | |||||||
Biopsy: | ||||||||
Vastus lateralis type I fibre CSA | ↑ | |||||||
Vastus lateralis type II fibre CSA | ↔ | |||||||
Strength: | ||||||||
1RM: | ||||||||
Knee extension | ↔ | |||||||
Isokinetic dynamometer IMVC: | ||||||||
Knee extension | ↔ | |||||||
Dalgaard et al., 2022* [19] |
OCP-users: 20 Naturally menstruating: 18 |
Untrained | 10 | Yes | Hypertrophy: | The use of a second-generation OCP in young untrained women does not promote significantly greater gains in muscle mass or muscle strength compared with non-users | 13 | |
DXA | ||||||||
Fat-free mass | ↔ | |||||||
MRI: | ||||||||
Vastus lateralis muscle CSA (10 cm) | ↔ | |||||||
Vastus lateralis muscle CSA (20 cm) | ↔ | |||||||
Vastus lateralis muscle CSA (30 cm) | ↔ | |||||||
Biopsy: | ||||||||
Vastus lateralis type I fibre CSA | ↔ | |||||||
Vastus lateralis type II fibre CSA | ↔ | |||||||
Power: | ||||||||
Counter-movement jump | ↔ | |||||||
Strength: | ||||||||
5RM: | ||||||||
Leg press | ↔ | |||||||
Isokinetic dynamometer IMVC: | ||||||||
Knee extension | ↔ | |||||||
Knee flexion | ↔ | |||||||
Nichols et al., 2008 [22] |
OCP-users: 13 Naturally menstruating: 18 |
Trained (NCAA Division 1 Collegiate Athletes) |
12 | NR | Strength: | The use of OCPs did not provide sufficient androgenic effect to increase strength gains beyond the stimulus of the training protocol | 6 | |
1RM: | ||||||||
Bench press | ↔ | |||||||
10RM: | ||||||||
Knee extension | ↔ | |||||||
Isokinetic dynamometer peak torque: | ||||||||
Bench press | ↔ | |||||||
Knee extension | ↔ | |||||||
Oxfeldt et al., 2020* [15] |
OCP-users: 20 Naturally menstruating: 18 |
Untrained | 10 | Yes | Hypertrophy: | Use of second-generation OCPs in young untrained women increased skeletal muscle MRF4 expression and satellite cell number compared with non-users | 13 | |
Biopsy: | ||||||||
Vastus lateralis type I fibre CSA | ↔ | |||||||
Vastus lateralis type II fibre CSA | ↔ | |||||||
Reichmann and Lee, 2021 [16] |
OCP-users: 34 Naturally menstruating: 38 |
Untrained | 10 | Yes | Hypertrophy: | OC use impairs muscle gains in young healthy untrained women, but the effect may depend on the type of OCPs | 9 | |
Hydrostatic weighing: | ||||||||
Lean mass | ↓ | |||||||
Strength: | ||||||||
1RM: | ||||||||
Arm strength (aggregated score) | ↔ | |||||||
Leg strength (aggregated score) | ↔ | |||||||
Romance et al., 2019 [23] |
OCP-users: 12 Naturally menstruating: 11 |
Trained (> 2 years’ continuous resistance exercise training) |
8 | Yes | Hypertrophy: |
OC use does not impair strength gains nor body composition in resistance-trained young adult women |
9 | |
DXA: | ||||||||
Fat-free mass | ↔ | |||||||
Power: | ||||||||
Counter-movement jump | ↔ | |||||||
Strength: | ||||||||
1RM: | ||||||||
Bench press | ↔ | |||||||
Squat | ↔ | |||||||
Sung et al., 2022 [24] |
OCP-users: 34 Naturally menstruating: 40 |
Untrained | 12 | Yes | Hypertrophy: | The effects of RET on muscle strength, muscle thickness, muscle fibre size and composition were similar in young women irrespective of their OCP use | 8 | |
Ultrasound: | ||||||||
Muscle thickness (sum of rectus femoris, vastus lateralis and vastus Intermedius) | ↔ | |||||||
Biopsy: | ||||||||
Vastus lateralis type I fibre muscle Thickness | ↔ | |||||||
Vastus lateralis type II fibre muscle thickness | ↔ | |||||||
Strength: | ||||||||
Combined force and load cell IMVC: | ||||||||
Leg press | ↔ | |||||||
Wikstrom-Frisen et al., 2017 [25] |
Group 1: OCP-users: 11 Naturally menstruating: 8 Group 2: OCP-users: 10 Naturally menstruating: 9 Group 3: OCP-users: 11 Naturally menstruating: 10 |
Trained (Mean resistance exercise training experience of 3.5 years) |
16 | Yes | Hypertrophy: | High-frequency periodised leg resistance training during the first 2 weeks of the menstrual/OCP cycle was more beneficial in terms of power gain, strength gain and increased leg lean mass compared with high-frequency resistance training during the last 2 weeks | 5 | |
DXA: | ||||||||
Leg lean mass | ↔ | |||||||
Whole body lean mass | ↔ | |||||||
Power: | ||||||||
Counter-movement jump | ↔ | |||||||
Squat jump | ↔ | |||||||
Strength: | ||||||||
Isokinetic dynamometer peak torque: | ||||||||
Single-leg knee extension (right and left) | ↔ | |||||||
Single-leg knee flexion (right and left) | ↔ |
CSA cross-sectional area, DXA dual-energy X-ray absorptiometry, IMVC isometric maximal voluntary contraction, MRI magnetic resonance imaging, NCAA National Collegiate Athletic Association, OCP oral contraceptive pill, RM repetition maximum
↑ = significant difference favouring OCP group; ↔ = No significant difference between groups; ↓ = significant difference favouring OCP non-users group
*Shared participants